Is Trelagliptin currently available in China?

Trelagliptin (Trelagliptin), as a new type of DPP-4 inhibitor, is currently receiving widespread attention worldwide, especially in the treatment of type 2 diabetes. It has significant efficacy. However, trotagliptin has not yet received marketing approval in China, which means that domestic patients are currently unable to purchase the drug through formal channels. Since trotagliptin has not yet been launched in China, its price is not yet clear domestically, and it is not eligible for the national medical insurance policy.

In overseas markets, especially in Japan, trolagliptin has been approved and marketed, becoming an effective drug for the treatment of type 2 diabetes. In Japan, the original version of trolagliptin is available in 20 tablets of 50 mg, with a price of approximately more than RMB 1,000 per box, while the price of 20 tablets of 100 mg may be as high as RMB 2,000. In addition, there are also generic drugs of Trelagliptin on the market in some other countries, such as Laos and Bangladesh. The ingredients of these generic drugs are basically the same as those of the original drug. Taking the Lao version of troagliptin as an example, its price is relatively low, ranging from RMB 100 to RMB 600. Price fluctuations are usually related to the supply and demand in the local market.

Although trolagliptin has not yet been approved for marketing in China, as global research onDPP-4 inhibitors continues to deepen, there may be more clinical trial results and marketing information about this drug in the future. Once the drug is approved in China, it could become a new option for treating type 2 diabetes and help domestic patients better control blood sugar levels.

Therefore, patients who are in urgent need of the drug may need to purchase it through overseas channels, especially in markets such as Japan, where patients can obtain the drug with a prescription from a physician. However, patients should be aware that there are certain risks associated with purchasing drugs through informal channels. The source, transportation, and storage conditions of the drugs may affect the quality and efficacy of the drugs.

Reference materials:https://en.wikipedia.org/wiki/Trelagliptin